These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 19771176)
21. [Effect of baseline CD(4)(+) T cell count on drop-out of antiretroviral therapy in HIV infected persons in Guangxi Zhuang Autonomous Region, 2008-2015]. Liu XH; Zhu QY; Su JM; Meng Q; Zhou XJ; Shen ZY; Tang ZZ; Yang WM; Ruan YH; Shao YM Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Sep; 39(9):1216-1221. PubMed ID: 30293313 [No Abstract] [Full Text] [Related]
23. High turnaround times and low viral resuppression rates after reinforced adherence counselling following a confirmed virological failure diagnostic algorithm in HIV-infected patients on first-line antiretroviral therapy from Tanzania. Kroidl A; Burger T; Urio A; Mugeniwalwo R; Mgaya J; Mlagalila F; Hoelscher M; Däumer M; Salehe O; Sangare A; Lennemann T; Maganga L Trop Med Int Health; 2020 May; 25(5):579-589. PubMed ID: 31984634 [TBL] [Abstract][Full Text] [Related]
24. CD4 Count Recovery After Initiation of Antiretroviral Therapy in Patients Infected With Human Immunodeficiency Virus. Bishop JD; DeShields S; Cunningham T; Troy SB Am J Med Sci; 2016 Sep; 352(3):239-44. PubMed ID: 27650226 [TBL] [Abstract][Full Text] [Related]
25. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Idoko J; Meloni S; Muazu M; Nimzing L; Badung B; Hawkins C; Sankalé JL; Ekong E; Murphy R; Kanki P; Thio CL Clin Infect Dis; 2009 Oct; 49(8):1268-73. PubMed ID: 19772386 [TBL] [Abstract][Full Text] [Related]
26. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study. Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014 [TBL] [Abstract][Full Text] [Related]
27. Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed Individuals. Calkins KL; Lesko CR; Chander G; Moore RD; Lau B J Acquir Immune Defic Syndr; 2018 Mar; 77(3):317-324. PubMed ID: 29210833 [TBL] [Abstract][Full Text] [Related]
28. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. ; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126 [TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics of HIV-1-infected patients with high levels of plasma interferon-γ: a multicenter observational study. Watanabe D; Uehira T; Suzuki S; Matsumoto E; Ueji T; Hirota K; Minami R; Takahama S; Hayashi K; Sawamura M; Yamamoto M; Shirasaka T BMC Infect Dis; 2019 Jan; 19(1):11. PubMed ID: 30611204 [TBL] [Abstract][Full Text] [Related]
30. Visceral Leishmaniasis and HIV Co-Infection in Northwest Ethiopia: Antiretroviral Treatment and Burden of Disease among Patients Enrolled in HIV Care. van Griensven J; Simegn T; Endris M; Diro E Am J Trop Med Hyg; 2018 Feb; 98(2):486-491. PubMed ID: 29210347 [TBL] [Abstract][Full Text] [Related]
31. Effect of HIV and malaria parasites co-infection on immune-hematological profiles among patients attending anti-retroviral treatment (ART) clinic in Infectious Disease Hospital Kano, Nigeria. Jegede FE; Oyeyi TI; Abdulrahman SA; Mbah HA; Badru T; Agbakwuru C; Adedokun O PLoS One; 2017; 12(3):e0174233. PubMed ID: 28346490 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of Routine HIV Opt-Out Screening and Continuum of Care Services Following Entry into Eight Prison Reception Centers--California, 2012. Lucas KD; Eckert V; Behrends CN; Wheeler C; MacGowan RJ; Mohle-Boetani JC MMWR Morb Mortal Wkly Rep; 2016 Feb; 65(7):178-81. PubMed ID: 26914322 [TBL] [Abstract][Full Text] [Related]
33. Adherence to On-Time ART Drug Pick-Up and Its Association with CD4 Changes and Clinical Outcomes Amongst HIV Infected Adults on First-Line Antiretroviral Therapy in Nigerian Hospitals. Anoje C; Agu KA; Oladele EA; Badru T; Adedokun O; Oqua D; Khamofu H; Adebayo O; Torpey K; Chabikuli ON AIDS Behav; 2017 Feb; 21(2):386-392. PubMed ID: 27388161 [TBL] [Abstract][Full Text] [Related]
34. Factors associated with 10 years of continuous viral load suppression on HAART. Bello KJ; Mesner O; O'Bryan TA; Won SH; Lalani T; Ganesan A; Agan BK; Okulicz JF BMC Infect Dis; 2016 Jul; 16():351. PubMed ID: 27449671 [TBL] [Abstract][Full Text] [Related]
35. Virological Outcome After Choice of Antiretroviral Regimen Guided by Proviral HIV-1 DNA Genotyping in a Real-Life Cohort of HIV-Infected Patients. Meybeck A; Alidjinou EK; Huleux T; Boucher A; Tetart M; Choisy P; Bocket L; Ajana F; Robineau O AIDS Patient Care STDS; 2020 Feb; 34(2):51-58. PubMed ID: 32049556 [TBL] [Abstract][Full Text] [Related]
36. Determinants of loss to follow-up in patients on antiretroviral treatment, South Africa, 2004-2012: a cohort study. Mberi MN; Kuonza LR; Dube NM; Nattey C; Manda S; Summers R BMC Health Serv Res; 2015 Jul; 15():259. PubMed ID: 26141729 [TBL] [Abstract][Full Text] [Related]
37. Impact of polymorphisms in the HCP5 and HLA-C, and ZNRD1 genes on HIV viral load. Thørner LW; Erikstrup C; Harritshøj LH; Larsen MH; Kronborg G; Pedersen C; Larsen CS; Pedersen G; Gerstoft J; Obel N; Ullum H Infect Genet Evol; 2016 Jul; 41():185-190. PubMed ID: 27083073 [TBL] [Abstract][Full Text] [Related]
38. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study. Mocroft A; Phillips AN; Gatell J; Ledergerber B; Fisher M; Clumeck N; Losso M; Lazzarin A; Fatkenheuer G; Lundgren JD; Lancet; 2007 Aug; 370(9585):407-13. PubMed ID: 17659333 [TBL] [Abstract][Full Text] [Related]
39. Effect of schistosomiasis on the outcome of patients infected with HIV-1 starting antiretroviral therapy in rural Tanzania. Stete K; Glass TR; van Dam GJ; Ntamatungiro A; Letang E; de Dood CJ; Corstjens PLAM; Ndege R; Mapesi H; Kern WV; Hatz C; Weisser M; Utzinger J; Müller MC PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006844. PubMed ID: 30332404 [TBL] [Abstract][Full Text] [Related]
40. Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya. Brooks K; Diero L; DeLong A; Balamane M; Reitsma M; Kemboi E; Orido M; Emonyi W; Coetzer M; Hogan J; Kantor R J Int AIDS Soc; 2016; 19(1):20798. PubMed ID: 27231099 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]